Handelsavisen
prelaunch
Companies Basic Materials 300214.SZ
30
300214.SZ Shenzhen Stock Exchange Commodity Chemicals

Shandong Rike Chemical Co Ltd

¥8,70
Open in Charts → Attach watcher ⌖
CNY
Set alert
Last 30 days
1D5D1M3M6MYTD1Y5YMax
Live price chart loads from the market-data widget.
Mcap
P/E
EV / Rev
Div yield
0,00 %
Op margin
-4,0 %
ROE
-1,4 %
Net margin
-4,1 %
Debt / equity
0,55
Beta
52w range
Volume
Day range
Prev close
Open
Next earnings
Ex-dividend
TR 1Y
About

Shandong Rike Chemical Co Ltd is a Chinese chemical manufacturing company that produces and sells commodity chemicals, primarily serving industrial and agricultural markets.

Business. Shandong Rike Chemical Co Ltd (300214.SZ) is a Chinese company operating in the commodity chemicals industry within the basic materials sector. The firm is headquartered in China and is primarily listed on the Shenzhen Stock Exchange. Specific details regarding its operating segments and geographic revenue mix are not available.

Classification92 %
SectorBasic Materials
Business sectorChemicals
IndustryCommodity Chemicals
ActivityChemicals
Generated · model-assisted
Sell-side consensus
consensus pending
— buy— hold— sell
Avg 12m price target
Upcoming events
— missing data
See all catalysts →

At a glance

Score
not yet scored
Valuation
valuation pending
Analysts
not yet wired
Ownership
not yet wired
Profitability
-1,4 %
return on equity
Quality
not yet scored

What drives this business

The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.

— missing data

News & coverage

0
  • No recent newsroom coverage mentioning 300214.
  • Sector rotation

    Sector1D1Mvs mkt
    Materials · THIS SECTOR+2,3 %+6,6 %+1,7 %
    Communication Services+2,2 %−5,5 %+1,6 %
    Energy+0,6 %+3,3 %+0,0 %
    Health Care+0,6 %−0,8 %+0,0 %
    Information Technology+0,6 %+6,7 %+0,0 %
    Consumer Discretionary+0,4 %+7,6 %−0,2 %
    Financials−0,3 %−2,8 %−0,9 %
    Consumer Staples−0,4 %+2,5 %−1,0 %
    Real Estate−0,7 %+10,9 %−1,3 %
    Industrials−1,9 %−3,1 %−2,5 %
    Utilities−1,9 %+28,2 %−2,5 %

    Developing storylines

    No tracked sagas currently linked to 300214.SZ. Browse all sagas →

    Analysis

    AI analysis
    Generated · analysis pipeline · tier hybrid · as of 2026-08-04 ↑ At a glance

    Opportunity

    — missing data

    Upcoming catalysts

    Scheduled public events. Informational only — not investment advice.

    • Macro
    • Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
    • Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
    • Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
    • Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
    • Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
    • Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
    • Macro & political
    • ElectionSE Swedish Election2026-09-14 · SE
    • ElectionUS U.S. Midterms2026-11-03 · US
    • ElectionFR French Legislative2027-06-01 · FR

    Pre-earnings brief

    — missing data

    Signals & dispatch

    peak dispatch · —

    Composite-score breakdown

    Synthesis

    Business

    Shandong Rike Chemical Co Ltd (300214.SZ) is a Chinese company operating in the commodity chemicals industry within the basic materials sector. The firm is headquartered in China and is primarily listed on the Shenzhen Stock Exchange. Specific details regarding its operating segments and geographic revenue mix are not available.

    Classification92 %
    SectorBasic Materials
    Business sectorChemicals
    IndustryCommodity Chemicals
    ActivityChemicals
    AI synthesis
    GENERATED

    Shandong Rike Chemical Co Ltd has a debt-to-equity ratio of 0.55 and a current ratio of 1.14, indicating moderate leverage and limited short-term liquidity cushion. The company reported negative operating cash flow of -76.4 million CNY and capital expenditures of -405.8 million CNY, reflecting significant reinvestment in operations amid a challenging environment.

    Profitability metrics are weak, with a return on equity of -1.35% and a return on assets of -0.74%, both well below the typical performance of the Commodity Chemicals industry. The company reported a net loss of 33.6 million CNY and an operating loss of 32.97 million CNY, signaling operational distress.

    The company operates as a single business segment, with all revenue derived from commodity chemical production and sales. Geographic exposure is concentrated in China, with no disclosed international operations or revenue diversification.

    Revenue for the latest period was 821.44 million CNY, but the company has not provided forward-looking guidance. The outlook for the current fiscal year is uncertain, with no disclosed revenue growth or margin improvement expected in the near term.

    The company faces liquidity and operational risks, with negative operating cash flow and a net loss. The risk assessment indicates medium liquidity risk and low dilution risk, though the negative net cash position after subtracting total debt raises concerns about short-term solvency.

    Recent filings and transcripts have not disclosed any material events or strategic shifts. The company has not issued new shares or announced significant capital-raising activities in the latest reporting period.

    Key takeaways
    • Shandong Rike Chemical Co Ltd is operating at a net loss with negative operating cash flow and capital expenditures, indicating financial stress.
    • The company's return on equity and return on assets are negative, significantly underperforming industry norms.
    • Revenue is concentrated in a single business segment and geographic region, increasing exposure to local market risks.
    • Liquidity is moderate, but the negative net cash position after debt raises concerns about short-term solvency.
    • No recent strategic or capital-raising events have been disclosed, suggesting operational challenges without immediate relief.

    Bull / Bear case

    Generated · model-assisted
    BULL CASE · 5

    Free cash flow surged 105.4% year-over-year to CNY 29.5 million, signaling improved operational liquidity.

    Operating income improved 96.1% year-over-year, narrowing the loss to CNY 3.7 million in the latest period.

    Revenue grew 6.4% year-over-year to CNY 3.74 billion, demonstrating top-line expansion despite margin pressures.

    Cash conversion ratio of 2.27 exceeds the cohort median of 1.1, indicating superior cash generation efficiency.

    Net income improved 59.3% year-over-year, reducing the net loss to CNY 29.7 million in the latest period.

    BEAR CASE · 4

    The company faces high credit risk, posing significant potential challenges for debt servicing and financial stability.

    Long-term debt ballooned to CNY 1.94 billion, nearly doubling from the previous year's CNY 892.9 million.

    Operating and net margins remain negative at -4.0% and -4.1%, placing the firm in the bottom quartile.

    Return on equity is negative at -1.35%, significantly underperforming the cohort median of 3.61%.

    In focus — financials by report

    Quarterly
    Annual
    QUARTERLYFiled 2023-04-20
    Q1 2023 · Quarter highlights

    Revenue ¥986.6M; Operating income -¥5.8M.

    Revenue¥986.6M
    Operating income-¥5.8M
    Net income-¥10.0M
    Free cash flow
    EPS
    Operating cash flow-¥41.2M
    Financials
    Income statement
    Revenue¥986.6M
    Gross profit¥41.2M
    Operating income-¥5.8M
    Net income-¥10.0M
    Margins
    Gross margin4.2%
    Operating margin-0.6%
    Net margin-1.0%
    FCF margin
    Balance sheet
    Total assets¥4.96B
    Total liabilities¥2.50B
    Total equity¥2.46B
    Cash & equivalents¥220.7M
    Long-term debt¥1.42B
    Cash flow
    Operating cash flow-¥41.2M
    CapEx-¥490.4M
    Free cash flow
    SBC
    P&L flow · revenue → net income
    Revenue ¥986.6MOperating costs ¥992.4MTax ¥4.2MNet income ¥10.0M
    Highlights
    • Revenue ¥986.6M
    • Operating income -¥5.8M
    • Net margin -1.0%

    Valuation FY

    Market price
    ¥8,70
    Market cap
    Enterprise value
    P/E
    Non-GAAP P/E
    EV / Revenue
    EV / Op income
    EV / OCF
    P / B
    P / Tangible book
    Tangible book
    ¥2.49B
    Net cash
    -¥1.37B
    Current ratio
    1.1
    Debt / equity
    0.6
    ROA
    -0.7%
    ROE
    -1.4%
    Cash conversion
    227.0%
    CapEx / revenue
    -49.4%
    SBC / revenue
    Dilution ratio
    0.0%

    Revenue by segment

    Market share

    — missing data

    Business relationships

    — missing data

    Supply chain

    — missing data

    Peer comparison

    — missing data

    Market position

    Stress test

    — missing data

    Predictor forecast

    Options

    — missing data

    Short squeeze

    — missing data

    Earnings-call key lines

    — missing data

    Estimate revisions

    consensus EPS · 26-week trend
    — missing data

    Sell-side observations

    — missing data

    Themes

    — missing data

    ESG

    — missing data

    Risk factors

    Dilution riskLow
    Liquidity riskMedium
    Filing-based flags
    • Net cash is negative after subtracting total debt.

    Benchmarks vs cohort

    Op Margin-4,0 %Bottom quartile
    Net Margin-4,1 %Bottom quartile
    ROE-1,4 %Bottom quartile
    Capex / Rev-49,4 %Bottom quartile
    D/E0,55Below median
    Cash Conv2,27Above median

    Corporate actions / M&A

    — missing data

    FX exposure

    — missing data

    Comparable transactions

    — missing data

    Derivatives & instruments

    — missing data

    Actions

    Ask Handelsavisen

    — missing data
    Data sources
    • Market data
    • Market data cache
    • Issuer disclosures
    • Public news
    • Earnings transcripts
    • Consensus estimates
    • ESG data
    How metrics are computed
    • Dilution Ratio
      (shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
    • Net Cash
      cash_and_equivalents + short_term_investments - short_term_debt - long_term_debt
    • Capex To Revenue
      capital_expenditure / revenue
    • Return On Equity
      net_income / total_equity
    • Debt To Equity
      (short_term_debt + long_term_debt) / total_equity
    • Cash Conversion Ratio
      operating_cash_flow / net_income
    Source documents
    • Shandong Rike Chemical Co Ltd Market data — financials · 2026-05-26

    Ownership & reference

    Insider activity

    — missing data

    Short positioning

    — missing data

    Geographic breakdown

    — missing data
    Listings · one canonical issuer all listings resolve to the canonical
    300214.SZCanonical
    Shenzhen Stock Exchange · CNY

    Intel & risk

    peak dispatch · —
    OSINT findings
    Dilution riskLow
    Liquidity riskMedium
    Net cash is negative after subtracting total debt.

    Evidence & claims

    From filings & derived data
    — missing data

    The Thread

    Everything we know, in order
    2023-04-20 15:39 UTCEARNINGSQuarterly results — Q1 2023 Revenue CNY 986.6M · Net CNY -10.0M
    2023-04-20 15:39 UTCEARNINGSAnnual results — FY 2023 Revenue CNY 3.52B · Net CNY -72.9M
    2022-10-21 14:11 UTCEARNINGSQuarterly results — Q3 2022 Revenue CNY 821.4M · Net CNY -33.6M
    2022-04-19 16:31 UTCEARNINGSAnnual results — FY 2022 Revenue CNY 2.54B · Net CNY 84.6M
    2021-03-01 18:37 UTCEARNINGSAnnual results — FY 2021 Revenue CNY 2.76B · Net CNY 196.5M
    2020-02-28 16:37 UTCEARNINGSAnnual results — FY 2020 Revenue CNY 2.77B · Net CNY 190.2M
    The entity's full life in the product — typed, chronological, joined across Newspaper, Platform and Data. Our memory, made visible.
    Sources filings · IR · transcripts · market data · tier hybrid · as of 2026-08-04 Market data · Issuer disclosures · Public news · Earnings transcripts · Consensus estimates · ESG data Premium coverage